Key result
ECMO yields ~33% survival to hospital discharge in neonates with severe enteroviral myocarditis.
Why the study?
ECMO is used for neonates with enteroviral myocarditis and medically refractory cardiopulmonary collapse, but its efficacy had not been systematically studied.
Cohort (n=24)
Yes
ECMO provides a 33% survival to hospital discharge rate in neonates with severe enteroviral myocarditis, though multisystem organ dysfunction portends a poor prognosis.
Answers are grounded in this paper and cite their sources.
ECMO in neonatal enteroviral myocarditis yields guarded survival; larger prospective studies needed to validate organ dysfunction as prognostic marker.
Objectives Neonates infected with enteroviruses may present with severe myocarditis and medically refractory cardiopulmonary collapse. Extracorporeal membrane oxygenation (ECMO) has been used to support patients in this setting, but its efficacy has not been systematically studied. We sought to review the Extracorporeal Life Support Organization registry to determine survival rates and identify predictors of in hospital mortality for these neonates. Design Retrospective cohort study using data reported to the Extracorporeal Life Support Organization registry. Setting Multi-institutional data. Patients Patients ≤ 15 days old with enteroviral myocarditis who required ECMO support between 2000 and 2008. Interventions None. Measurements and main results Twenty-four neonates with enteroviral myocarditis were reported to the Extracorporeal Life Support Organization registry during the study period. The survival to hospital discharge rate was 33% (n = 8). Multisystem organ dysfunction was more common in nonsurvivors than in survivors (75% vs. 0%, p < .01). In particular, nonsurvivors had a higher prevalence of renal dysfunction (50% vs. 0%, p = .02). Nonsurvivors also had a greater number of ECMO-related complications (5 vs. 3.5, p = .03). Conclusions Cardiopulmonary support with ECMO should be considered for neonates with severe enteroviral myocarditis that fails conventional medical therapies. Multisystem organ dysfunction, particularly with renal involvement, may portend a poor prognosis and is one of several factors that should be considered in the decision to initiate and/or continue mechanical support for these patients.
No takes yet. Share an insight, caveat, or question.
Madden et al. (2010) conducted a cohort in Enteroviral myocarditis requiring extracorporeal membrane oxygenation (ECMO) (n=24). Extracorporeal membrane oxygenation (ECMO) was evaluated on Survival to hospital discharge. ECMO support in neonates with severe enteroviral myocarditis resulted in a 33% survival to hospital discharge rate, with higher multisystem organ dysfunction in nonsurvivors.
Synapse has enriched 10 related papers. Consider them for comparative context: